Structural Analysis and Lipid-Binding Properties of Recombinant Human Surfactant Protein A Derived from One or Both Genes
Authors:
- 30 October 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (47) , 14041-14053
Abstract
Surfactant protein A (SP-A) constitutes an important part of the innate immune defense in the lung. In humans there are two functional genes (SP-A1 and SP-A2). The functional importance of having two distinct chain types in human SP-A is undefined. Amino acid substitutions in the primary structure of the protein may have effects on structural stability or on activity. To address this issue, SP-A1, SP-A2, and coexpressed SP-A1/SP-A2 variants were in vitro expressed in insect cells, purified, and used for study. We found the following: (1) Human SP-A variants expressed in insect cells, derived from one gene (SP-A1 or SP-A2) or both genes, differ in the relative extent and heterogeneity of oligomerization. SP-A1 and SP-A2 exist in small oligomeric forms, whereas coexpressed SP-A1/SP-A2 products favor the formation of larger oligomers. (2) Circular dichroic and fluorescence spectroscopic studies identified structural differences between SP-A variants in the collagen domain, with SP-A2 being more stable than SP-A1 but not in the calcium binding region. Recombinant human SP-A variants expressed in insect cells exhibit a lower melting temperature compared to native human SP-A. Oligomerization does not increase the thermal stability of the collagen domain of coexpressed SP-A1/SP-A2. (3) The ability of SP-A to undergo self-aggregation and induce phospholipid and bacterial lipopolysaccharide aggregation is greater for SP-A2 than for coexpressed SP-A1/SP-A2, which in turn is greater than that observed for SP-A1. The presence of SP-A1 polypeptide chains in coexpressed products modulates functional capabilities of SP-A, which depend on both the collagen and globular domains.Keywords
This publication has 24 references indexed in Scilit:
- The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lungJournal of Clinical Investigation, 2002
- The effect of ozone exposure on the ability of human surfactant protein a variants to stimulate cytokine production.Environmental Health Perspectives, 2002
- Surfactant Proteins A and D and Pulmonary Host DefenseAnnual Review of Physiology, 2001
- Structural characterisation of human proteinosis surfactant protein ABiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Human SP-A protein variants derived from one or both genes stimulate TNF-α production in the THP-1 cell lineAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2000
- Surfactant Protein A2 Gene Expression by Human Airway Submucosal Gland CellsAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humansBiochemical Journal, 1997
- 5′ Splicing and Allelic Variants of the Human Pulmonary Surfactant Protein a GenesAmerican Journal of Respiratory Cell and Molecular Biology, 1995
- Structural Comparison of Recombinant Pulmonary Surfactant Protein SP-A Derived from Two Human Coding Sequences: Implications for the Chain Composition of Natural Human SP-AAmerican Journal of Respiratory Cell and Molecular Biology, 1991
- Macromolecular organization of natural and recombinant lung surfactant protein SP 28–36Journal of Molecular Biology, 1988